NO913684D0 - Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. - Google Patents
Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.Info
- Publication number
- NO913684D0 NO913684D0 NO913684A NO913684A NO913684D0 NO 913684 D0 NO913684 D0 NO 913684D0 NO 913684 A NO913684 A NO 913684A NO 913684 A NO913684 A NO 913684A NO 913684 D0 NO913684 D0 NO 913684D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- inhibitors
- procedure
- calcium
- recording
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/08—Preparation by ring-closure
- C07D213/09—Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles
- C07D213/10—Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles from acetaldehyde or cyclic polymers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58541290A | 1990-09-20 | 1990-09-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO913684D0 true NO913684D0 (no) | 1991-09-19 |
| NO913684L NO913684L (no) | 1992-03-23 |
Family
ID=24341317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91913684A NO913684L (no) | 1990-09-20 | 1991-09-19 | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5500429A (no) |
| EP (1) | EP0476646B1 (no) |
| JP (1) | JP3031766B2 (no) |
| KR (1) | KR100198040B1 (no) |
| CN (1) | CN1063685A (no) |
| AT (1) | ATE154011T1 (no) |
| AU (1) | AU653957B2 (no) |
| CA (1) | CA2051494C (no) |
| DE (1) | DE69126392T2 (no) |
| ES (1) | ES2106042T3 (no) |
| FI (1) | FI914409L (no) |
| HU (1) | HUT59099A (no) |
| IE (1) | IE913300A1 (no) |
| IL (1) | IL99515A0 (no) |
| NO (1) | NO913684L (no) |
| NZ (1) | NZ239864A (no) |
| PT (1) | PT99011A (no) |
| TW (1) | TW205548B (no) |
| ZA (1) | ZA917371B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU640523B2 (en) * | 1990-09-20 | 1993-08-26 | Merrell Dow Pharmaceuticals Inc. | 1-phenyl-3-aryl-2-propyne-1-ones |
| KR0130883Y1 (ko) * | 1994-02-02 | 1998-12-15 | 김광호 | 컴퓨터의 하드 디스크 드라이버 착탈장치 |
| KR20040100835A (ko) | 2001-02-15 | 2004-12-02 | 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 | 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법 |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| EP1632281B1 (en) | 2003-12-15 | 2011-09-14 | Rohm And Haas Company | Process for absorbing hydrophobic substances in polymers having an hollow structure |
| WO2006010379A1 (en) | 2004-07-29 | 2006-02-02 | Actelion Pharmaceuticals Ltd. | Novel thiophene derivatives as immunosuppressive agents |
| CA2602478A1 (en) | 2005-03-23 | 2006-09-28 | Actelion Pharmaceuticals Ltd | Novel thiophene derivatives |
| PL1863787T3 (pl) | 2005-03-23 | 2011-10-31 | Idorsia Pharmaceuticals Ltd | Uwodornione pochodne benzo[c]tiofenu jako immunomodulatory |
| EP1896446A1 (en) | 2005-06-24 | 2008-03-12 | Actelion Pharmaceuticals Ltd. | Novel thiophene derivatives |
| WO2007032591A1 (en) * | 2005-09-13 | 2007-03-22 | Industry-Academic Cooperation Foundation, Yeungnam University | Composition comprising 1-furan-2-yl-3-pyridin-2-yl-pr0pen0ne having anti-angiogenic activity and cancer growth inhibitory activity |
| KR100779610B1 (ko) * | 2005-09-13 | 2007-11-28 | 영남대학교 산학협력단 | 1-퓨란-2-일-3-피리딘-2-일-프로페논을 함유하는혈관신생으로 인한 질환 및 암질환의 예방 또는 치료용약학조성물 |
| AR057894A1 (es) | 2005-11-23 | 2007-12-26 | Actelion Pharmaceuticals Ltd | Derivados de tiofeno |
| EP1979345B1 (en) | 2006-01-24 | 2009-11-04 | Actelion Pharmaceuticals Ltd. | Novel pyridine derivatives |
| CN101511827B (zh) | 2006-09-07 | 2012-02-01 | 埃科特莱茵药品有限公司 | 作为免疫调制剂的吡啶-4-基衍生物 |
| AR061841A1 (es) | 2006-09-07 | 2008-09-24 | Actelion Pharmaceuticals Ltd | Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores. |
| CA2661315C (en) | 2006-09-08 | 2015-11-24 | Actelion Pharmaceuticals Ltd | Pyridin-3-yl derivatives as immunomodulating agents |
| SI2125797T1 (sl) | 2007-03-16 | 2014-03-31 | Actelion Pharmaceuticals Ltd. | Derivati amino-piridina kot agonisti receptorja s1p1/edg1 |
| NZ588438A (en) | 2008-03-07 | 2012-05-25 | Actelion Pharmaceuticals Ltd | Pyridin-2-yl oxadiazole derivatives as immunomodulating agents |
| EP2454255B1 (en) | 2009-07-16 | 2013-11-06 | Actelion Pharmaceuticals Ltd. | Pyridin-4-yl derivatives as s1p1/edg1 agonists |
| WO2011109551A2 (en) * | 2010-03-03 | 2011-09-09 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| ES2544086T3 (es) | 2011-01-19 | 2015-08-27 | Actelion Pharmaceuticals Ltd. | Derivados de 2-metoxi-piridin-4-ilo |
| JP2014100171A (ja) * | 2012-11-16 | 2014-06-05 | Hayashi Bussan Co Ltd | 商品落下防止具 |
| PH12017502097B1 (en) | 2015-05-20 | 2023-05-05 | Idorsia Pharmaceuticals Ltd | Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3409424A (en) * | 1966-03-01 | 1968-11-05 | Ethyl Corp | Propynones as defoliants |
| FR2081591A1 (en) * | 1970-03-27 | 1971-12-10 | Unicler | 2, 4-dimethoxyphenyl beta-pyrid-4-ylvinyl ketone - for treating capillary fragility and permeability |
| BE789099A (fr) * | 1971-09-22 | 1973-03-21 | Boehringer Sohn Ingelheim | Nouveaux derives de la pyridine et procede pour les fabriquer |
| FR2387956A1 (fr) * | 1977-04-20 | 1978-11-17 | Unicler | Derives de la pyridine et leur preparation |
| US4582836A (en) * | 1985-01-09 | 1986-04-15 | Mcneilab, Inc. | Octahydroindolizine compounds useful as analgesics |
| DK49688A (da) * | 1987-03-20 | 1988-09-21 | Hoffmann La Roche | Propiolophenonderivater |
-
1991
- 1991-09-16 CA CA002051494A patent/CA2051494C/en not_active Expired - Lifetime
- 1991-09-16 AU AU84529/91A patent/AU653957B2/en not_active Ceased
- 1991-09-16 ZA ZA917371A patent/ZA917371B/xx unknown
- 1991-09-17 IL IL99515A patent/IL99515A0/xx unknown
- 1991-09-17 TW TW080107366A patent/TW205548B/zh active
- 1991-09-18 CN CN91109004A patent/CN1063685A/zh active Pending
- 1991-09-19 HU HU913010A patent/HUT59099A/hu unknown
- 1991-09-19 FI FI914409A patent/FI914409L/fi unknown
- 1991-09-19 IE IE330091A patent/IE913300A1/en unknown
- 1991-09-19 PT PT99011A patent/PT99011A/pt not_active Application Discontinuation
- 1991-09-19 DE DE69126392T patent/DE69126392T2/de not_active Expired - Lifetime
- 1991-09-19 ES ES91115932T patent/ES2106042T3/es not_active Expired - Lifetime
- 1991-09-19 AT AT91115932T patent/ATE154011T1/de not_active IP Right Cessation
- 1991-09-19 EP EP91115932A patent/EP0476646B1/en not_active Expired - Lifetime
- 1991-09-19 NZ NZ239864A patent/NZ239864A/en unknown
- 1991-09-19 NO NO91913684A patent/NO913684L/no unknown
- 1991-09-20 JP JP3268508A patent/JP3031766B2/ja not_active Expired - Lifetime
- 1991-09-20 KR KR1019910016526A patent/KR100198040B1/ko not_active Expired - Fee Related
-
1993
- 1993-11-17 US US08/154,146 patent/US5500429A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT99011A (pt) | 1992-08-31 |
| JP3031766B2 (ja) | 2000-04-10 |
| CN1063685A (zh) | 1992-08-19 |
| FI914409A0 (fi) | 1991-09-19 |
| US5500429A (en) | 1996-03-19 |
| EP0476646A1 (en) | 1992-03-25 |
| AU8452991A (en) | 1992-03-26 |
| FI914409A7 (fi) | 1992-03-21 |
| ATE154011T1 (de) | 1997-06-15 |
| IL99515A0 (en) | 1992-08-18 |
| NO913684L (no) | 1992-03-23 |
| CA2051494C (en) | 2006-03-14 |
| KR100198040B1 (ko) | 1999-06-15 |
| JPH06271540A (ja) | 1994-09-27 |
| DE69126392D1 (de) | 1997-07-10 |
| FI914409L (fi) | 1992-03-21 |
| EP0476646B1 (en) | 1997-06-04 |
| HUT59099A (en) | 1992-04-28 |
| ZA917371B (en) | 1992-06-24 |
| AU653957B2 (en) | 1994-10-20 |
| IE913300A1 (en) | 1992-02-25 |
| DE69126392T2 (de) | 1998-01-22 |
| ES2106042T3 (es) | 1997-11-01 |
| TW205548B (no) | 1993-05-11 |
| KR920006316A (ko) | 1992-04-27 |
| CA2051494A1 (en) | 1992-03-21 |
| NZ239864A (en) | 1994-05-26 |
| HU913010D0 (en) | 1992-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO913684L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
| DE3060801D1 (en) | 4-substituted-3-hydroxy-3-pyrroline-2,5-dione compounds, process for their preparation and pharmaceutical compositions containing the same | |
| AU578050B2 (en) | Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them | |
| ATE2271T1 (de) | 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung. | |
| RU94031126A (ru) | Циклические мочевины и их аналоги, пригодные в качестве ингибиторов протеазы ретровирусов, способ лечения вирусных инфекций, фармацевтическая композиция | |
| ATE85523T1 (de) | Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. | |
| NO913683L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
| BG102553A (en) | Thiol derivatives having metallopeptidase inhibitor activity | |
| ATE151288T1 (de) | N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt | |
| SE8600658D0 (sv) | Novel composition of matter | |
| NO913685D0 (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
| IL61989A (en) | 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them | |
| DK576887A (da) | Farmaceutiske midler | |
| ATE175349T1 (de) | Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie |